Written by MarketBeatAugust 12, 2025 ShareLink copied to clipboard. Key Points MarketBeat highlights seven pharmaceutical stocks to consider, including Eli Lilly, Cardinal Health, and Pfizer, based on recent trading volume and market performance. Eli Lilly's stock recently rose to $638.36 after a mid-day trading increase, despite a 14% slide following earnings release. 180 Life Sciences saw a notable rise, with its stock trading up $8.68 to reach $12.02, reflecting significant trading volume compared to its average. Looking to export and analyze Eli Lilly and Company data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount. Like this article? Share it with a colleague. Link copied to clipboard. Featured Articles and OffersTrump GLP-1 Pilot Program Could Boost Novo Nordisk & Eli LillyBy Jordan Chussler | August 9, 2025BREAKING: The House just passed 3 pro-crypto bills!From Crypto 101 Media (Ad)3 AI Infrastructure Stocks Powering the Next Tech RevolutionBy Ryan Hasson | August 8, 2025An Atomic Sized Surge Is Brewing for NuScale Power Stock PriceBy Thomas Hughes | August 11, 2025IPO Market Stays Hot With These 2 Debuting StocksBy Dan Schmidt | August 11, 2025The stealth altcoin the financial world is underestimatingFrom Crypto 101 Media (Ad)SoundHound AI (NASDAQ:SOUN) Shares Down 3.3% - Here's WhyBy MarketBeat | August 9, 2025IBM: The Last Time This Happened, the Stock Rallied 35%By Sam Quirke | August 12, 2025 May 23, 2025ACT FAST! Congress Is POURING Into This StockLawmakers are making big trades again; Chris Markoch shares 3 big congressional buys, including one surprising pick that’s down over 30%.Watch VideoRecent Videos Stock ListsAll Stock Lists5G Biotech Blue Chip FAANG Gold Large Cap Marijuana Micro Cap Oil REITs Russell 2000 Small Cap Warren Buffett Investing ToolsCalendars and ToolsAnalyst RatingsCryptocurrency ScreenerCongressional TradingDividend IncreasesDividend CalculatorDividend CalendarEarnings AnnouncementsInsider TradesOptions Profit CalculatorPenny StocksPortfolio MonitoringShort InterestStock ComparisonsStock Market HolidaysStock Screener Search Headlines Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Written by MarketBeatAugust 12, 2025 ShareLink copied to clipboard. Key Points MarketBeat highlights seven pharmaceutical stocks to consider, including Eli Lilly, Cardinal Health, and Pfizer, based on recent trading volume and market performance. Eli Lilly's stock recently rose to $638.36 after a mid-day trading increase, despite a 14% slide following earnings release. 180 Life Sciences saw a notable rise, with its stock trading up $8.68 to reach $12.02, reflecting significant trading volume compared to its average. Looking to export and analyze Eli Lilly and Company data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount. Like this article? Share it with a colleague. Link copied to clipboard.
MarketBeat All Access